Johnson & Johnson Tops Profit Estimates but Trims Full-Year Sales Guidance
marketwatch.com
news
2022-10-18 10:38:00

Johnson & Johnson's third-quarter adjusted earnings topped analysts' estimates but the healthcare giant cut its sales guidance for the year.

Johnson & Johnson (ticker: JNJ) posted adjusted earnings of $2.55 a share on sales of $23.8 billion.

Analysts surveyed by FactSet expected the healthcare giant to report earnings of $2.48 a share on revenue of about $23.4 billion. A year earlier, Johnson & Johnson posted a profit of $2.60 a share on sales of $23.3 billion.

The company said it expects sales in 2022 of $93 billion to $93.
